BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35351656)

  • 1. FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.
    Chen Z; Wang S; Li HL; Luo H; Wu X; Lu J; Wang HW; Chen Y; Chen D; Wu WT; Zhang S; He Q; Lu D; Liu N; You Y; Wu W; Wang H
    Mol Ther; 2022 Jul; 30(7):2568-2583. PubMed ID: 35351656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
    Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma.
    Tang G; Luo L; Zhang J; Zhai D; Huang D; Yin J; Zhou Q; Zhang Q; Zheng G
    Cancer Lett; 2021 Feb; 498():152-164. PubMed ID: 33130316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
    Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
    Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
    Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
    Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
    Zhang Z; Xu J; Chen Z; Wang H; Xue H; Yang C; Guo Q; Qi Y; Guo X; Qian M; Wang S; Qiu W; Gao X; Zhao R; Guo X; Li G
    Cancer Immunol Res; 2020 Jul; 8(7):966-981. PubMed ID: 32350000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
    Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell signature in glioblastoma: therapeutic development for a moving target.
    Nakano I
    J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1.
    Marques C; Unterkircher T; Kroon P; Oldrini B; Izzo A; Dramaretska Y; Ferrarese R; Kling E; Schnell O; Nelander S; Wagner EF; Bakiri L; Gargiulo G; Carro MS; Squatrito M
    Elife; 2021 Aug; 10():. PubMed ID: 34399888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF-κB/STAT3 Signaling.
    Schweiger MW; Li M; Giovanazzi A; Fleming RL; Tabet EI; Nakano I; Würdinger T; Chiocca EA; Tian T; Tannous BA
    Adv Biosyst; 2020 Dec; 4(12):e1900312. PubMed ID: 32519463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.
    Narayanan A; Gagliardi F; Gallotti AL; Mazzoleni S; Cominelli M; Fagnocchi L; Pala M; Piras IS; Zordan P; Moretta N; Tratta E; Brugnara G; Altabella L; Bozzuto G; Gorombei P; Molinari A; Padua RA; Bulfone A; Politi LS; Falini A; Castellano A; Mortini P; Zippo A; Poliani PL; Galli R
    Cell Death Differ; 2019 Sep; 26(9):1813-1831. PubMed ID: 30538287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells.
    Cheng P; Phillips E; Kim SH; Taylor D; Hielscher T; Puccio L; Hjelmeland AB; Lichter P; Nakano I; Goidts V
    Stem Cell Reports; 2015 May; 4(5):899-913. PubMed ID: 25921812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
    Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
    J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
    Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
    J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling distinguishes proneural glioma stem cells from mesenchymal glioma stem cells.
    Chandran UR; Luthra S; Santana-Santos L; Mao P; Kim SH; Minata M; Li J; Benos PV; DeWang M; Hu B; Cheng SY; Nakano I; Sobol RW
    Genom Data; 2015 Sep; 5():333-336. PubMed ID: 26251826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Key Signaling Pathways in Glioblastoma Stem Cells for the Development of Efficient Chemo- and Immunotherapy.
    Helweg LP; Storm J; Witte KE; Schulten W; Wrachtrup L; Janotte T; Kitke A; Greiner JFW; Knabbe C; Kaltschmidt B; Simon M; Kaltschmidt C
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
    Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
    Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.
    Song Y; Jiang Y; Tao D; Wang Z; Wang R; Wang M; Han S
    Neuro Oncol; 2020 Jan; 22(1):46-57. PubMed ID: 31400279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.
    Moreno M; Pedrosa L; Paré L; Pineda E; Bejarano L; Martínez J; Balasubramaniyan V; Ezhilarasan R; Kallarackal N; Kim SH; Wang J; Audia A; Conroy S; Marin M; Ribalta T; Pujol T; Herreros A; Tortosa A; Mira H; Alonso MM; Gómez-Manzano C; Graus F; Sulman EP; Piao X; Nakano I; Prat A; Bhat KP; de la Iglesia N
    Cell Rep; 2017 Nov; 21(8):2183-2197. PubMed ID: 29166609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal Activity Promotes Glioma Progression by Inducing Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
    Guo X; Qiu W; Wang C; Qi Y; Li B; Wang S; Zhao R; Cheng B; Han X; Du H; Gao Z; Pan Z; Zhao S; Li G; Xue H
    Cancer Res; 2024 Feb; 84(3):372-387. PubMed ID: 37963207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.